Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025)
Whitehawk Therapeutics (WHWK) posted quarterly Change in Receivables of $1.0 million for Q1 2025, up 280.18% year-over-year from $263033.2 in Q1 2024, and up 256.99% quarter-over-quarter from -$637000.0 in Q4 2024.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Change in Receivables for 8 consecutive years, with $1.0 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Change in Receivables rose 280.18% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 140.96% YoY), while the FY2025 annual figure was $1.0 million, up 140.96% from the prior year.
- Change in Receivables improved to $1.0 million in Q1 2025 per WHWK's latest filing, from -$637000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $3.7 million in Q1 2023 and bottomed at -$14.0 million in Q1 2021.
- Historically, Change in Receivables has averaged -$483066.7 across 5 years, with a median of -$120000.0 in 2021.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 437.5% — and 2023, when it jumped 930.81%.
- Whitehawk Therapeutics' Change in Receivables stood at -$120000.0 in 2021, then tumbled by 232.5% to -$399000.0 in 2022, then surged by 42.61% to -$229000.0 in 2023, then tumbled by 178.17% to -$637000.0 in 2024, then soared by 256.99% to $1.0 million in 2025.
- Business Quant data shows WHWK's Change in Receivables at $1.0 million in Q1 2025, -$637000.0 in Q4 2024, and $620000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -637,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | -399,000.00 |
| Sep 30, 2022 | 198,000.00 |
| Jun 30, 2022 | -645,000.00 |
| Mar 31, 2022 | 2.71 Mn |
| Jun 30, 2021 | -120,000.00 |
| Mar 31, 2021 | -14.03 Mn |
| Dec 31, 2020 | 13.92 Mn |
| Dec 31, 2017 | -39,246.00 |
| Sep 30, 2017 | 34,982.00 |
| Jun 30, 2017 | -28,189.00 |
| Mar 31, 2017 | 28,296.00 |